Patents by Inventor Stephen Andruski

Stephen Andruski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • (S)--methylnaltrexone
    Patent number: 8916581
    Abstract: This invention relates to S-MNTX, methods of producing S-MNTX, pharmaceutical preparations comprising S-MNTX and methods for their use.
    Type: Grant
    Filed: June 23, 2011
    Date of Patent: December 23, 2014
    Assignee: Progenics Pharmaceuticals, Inc.
    Inventors: Thomas A. Boyd, Howard Wagoner, Suketu P. Sanghvi, Christopher Verbicky, Stephen Andruski
  • (S)-N-METHYLNALTREXONE
    Publication number: 20120136019
    Abstract: This invention relates to S-MNTX, methods of producing S-MNTX, pharmaceutical preparations comprising S-MNTX and methods for their use.
    Type: Application
    Filed: June 23, 2011
    Publication date: May 31, 2012
    Applicant: Progenics Pharmaceuticals, Inc.
    Inventors: Thomas A. Boyd, Howard Wagoner, Suketu P. Sanghvi, Christopher Verbicky, Stephen Andruski
  • ()--methylnaltrexone
    Patent number: 8003794
    Abstract: This invention relates to S-MNTX, methods of producing S-MNTX, pharmaceutical preparations comprising S-MNTX and methods for their use.
    Type: Grant
    Filed: July 20, 2009
    Date of Patent: August 23, 2011
    Assignee: Progenics Pharmaceuticals, Inc.
    Inventors: Thomas A. Boyd, Howard Wagoner, Suketu P. Sanghvi, Christopher Verbicky, Stephen Andruski
  • (S)-N-methylnal trexone
    Publication number: 20100105911
    Abstract: This invention relates to S-MNTX, methods of producing S-MNTX, pharmaceutical preparations comprising S-MNTX and methods for their use.
    Type: Application
    Filed: July 20, 2009
    Publication date: April 29, 2010
    Inventors: Thomas A. Boyd, Howard Wagoner, Suketu P. Sanghvi, Christopher Verbicky, Stephen Andruski
  • (S)--methylnaltrexone
    Patent number: 7563899
    Abstract: This invention relates to S-MNTX, methods of producing S-MNTX, pharmaceutical preparations comprising S-MNTX and methods for their use.
    Type: Grant
    Filed: May 25, 2006
    Date of Patent: July 21, 2009
    Assignee: Progenics Pharmaceuticals, Inc.
    Inventors: Thomas A. Boyd, Howard Wagoner, Suketu P. Sanghvi, Christopher Verbicky, Stephen Andruski
  • (S)-N-methylnaltrexone
    Publication number: 20070265293
    Abstract: This invention relates to S-MNTX, methods of producing S-MNTX, pharmaceutical preparations comprising S-MNTX and methods for their use.
    Type: Application
    Filed: May 25, 2006
    Publication date: November 15, 2007
    Inventors: Thomas Boyd, Howard Wagoner, Suketu Sanghvi, Christopher Verbicky, Stephen Andruski